Advanced search
Publication Cover
Clinical Ophthalmology Volume 9, 2015 - Issue
Submit an article Journal homepage
68
Views
8
CrossRef citations to date
0
Altmetric
Original Research

Intravitreal pegaptanib for the treatment of ischemic diabetic macular edema

Christine A KiireOxford Eye Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK
,
Rupal MorjariaOxford Eye Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK
,
Anna RudenkoOxford Eye Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK
,
Alexina FantatoOxford Eye Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK
,
Lewis SmithOxford Eye Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK
,
Amy SmithOxford Eye Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK
&
Victor ChongOxford Eye Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UKCorrespondence[email protected]
 show all
Pages 2305-2311 | Published online: 11 Dec 2015

References

  • MossSEKleinRKleinBETen-year incidence of visual loss in a diabetic populationOphthalmology19941016106110708008348
  • PaulusYMGarianoRFDiabetic retinopathy: a growing concern in an aging populationGeriatrics2009642162019256582
  • HiraiFEKnudtsonMDKleinBEKleinRClinically significant macular edema and survival in type 1 and type 2 diabetesAm J Ophthalmol2008145470070618226797
  • ParravanoMMenchiniFVirgiliGAntiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular oedemaCochrane Database Syst Rev20094CD00741919821414
  • SimDAKeanePAZarranz-VenturaJThe effects of macular ischemia on visual acuity in diabetic retinopathyInvest Ophthalmol Vis Sci20135432353236023449720
  • Classification of diabetic retinopathy from fluorescein angiogramsETDRS report number 11Early Treatment Diabetic Retinopathy Study Research GroupOphthalmology1991985 suppl8078222062514
  • ArendOWolfSHarrisAReimMThe relationship of macular microcirculation to visual acuity in diabetic patientsArch Ophthalmol199511356106147748131
  • NguyenQDBrownDMMarcusDMRISE and RIDE Research GroupRanibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDEOphthalmology2012119478980122330964
  • NakamuraYTakedaNTatsumiTMacular ischemia following intravitreal bevacizumab therapy for diabetic macular edemaNippon Ganka Gakkai Zasshi20121162108113 Japanese22509699
  • TichoUPatzAThe role of capillary perfusion in the management of diabetic macular edemaAm J Ophthalmol19737668808864796764
  • JonasJBMartusPDegenringRFKreissigIAkkoyunIPredictive factors for visual acuity after intravitreal triamcinolone treatment for diabetic macular edemaArch Ophthalmol2005123101338134316219724
  • ChungEJRohMIKwonOWKohHJEffects of macular ischemia on the outcome of intravitreal bevacizumab therapy for diabetic macular edemaRetina200828795796318698297
  • SingermanLJMasonsonHPatelMPegaptanib sodium for neovascular age-related macular degeneration: third-year safety results of the VEGF inhibition study in ocular neovascularisation (VISION) trialBr J Ophthalmol200892121606161118614570
  • NgEWAdamisAPAnti-VEGF aptamer (pegaptanib) therapy for ocular vascular diseasesAnn N Y Acad Sci2006108215117117145936
  • SultanMBZhouDLoftusJDombiTIceKSA phase 2/3, multicenter, randomized, double-masked, 2-year trial of pegaptanib sodium for the treatment of diabetic macular edemaOphthalmology201111861107111821529957
  • AbharySBurdonKPGuptaACommon sequence variation in the VEGFA gene predicts risk of diabetic retinopathyInvest Ophthalmol Vis Sci200950125552555819553626

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.